Organization

The Moncton City Hospital

2 abstracts

Abstract
Artemin and immune checkpoint inhibitor (ICI) efficacy in metastatic colorectal cancer (mCRC): A correlative analysis of the Canadian Cancer Trials Group (CCTG) CO.26 trial.
Org: Princess Margaret Cancer Centre, University Health Network, Genome Sciences Centre, BCCA, The Ottawa Hospital Cancer Centre, Oregon Health & Science University,
Abstract
Plasma arginine as a candidate predictive biomarker for response to immune checkpoint inhibition (ICI) in metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial.
Org: University Health Network, BCCA Vancouver Cancer Centre, The Ottawa Hospital Cancer Centre, Providence Cancer Institute, Queen's University, Belfast,